SK166199A3 - 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application - Google Patents
5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application Download PDFInfo
- Publication number
- SK166199A3 SK166199A3 SK1661-99A SK166199A SK166199A3 SK 166199 A3 SK166199 A3 SK 166199A3 SK 166199 A SK166199 A SK 166199A SK 166199 A3 SK166199 A3 SK 166199A3
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- formula
- alkyl
- naphthyl
- mmol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9706945A FR2764288B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
FR9706946A FR2764289B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
FR9706944A FR2764287B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique |
FR9706947A FR2764291B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
PCT/FR1998/001113 WO1998055474A1 (fr) | 1997-06-05 | 1998-06-03 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
SK166199A3 true SK166199A3 (en) | 2000-06-12 |
Family
ID=27447000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1661-99A SK166199A3 (en) | 1997-06-05 | 1998-06-03 | 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0986552A1 (fr) |
JP (1) | JP2002502412A (fr) |
KR (1) | KR20010013435A (fr) |
CN (1) | CN1265658A (fr) |
AR (1) | AR012908A1 (fr) |
AU (1) | AU8025198A (fr) |
BG (1) | BG103937A (fr) |
BR (1) | BR9810742A (fr) |
CA (1) | CA2290695A1 (fr) |
CO (1) | CO4940480A1 (fr) |
EE (1) | EE9900560A (fr) |
HU (1) | HUP0002166A3 (fr) |
IL (1) | IL133242A0 (fr) |
NO (1) | NO995966L (fr) |
PL (1) | PL337234A1 (fr) |
SK (1) | SK166199A3 (fr) |
TR (1) | TR199903022T2 (fr) |
WO (1) | WO1998055474A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002007822A2 (fr) * | 2000-07-21 | 2002-01-31 | Ortho-Mcneil Pharmaceutical, Inc. | Composes de carbamate destines a la prevention ou au traitement de douleurs neuropathiques et de douleurs associees a la cephalee vasculaire de horton et a la migraine |
FR2843964B1 (fr) | 2002-08-29 | 2004-10-01 | Sanofi Synthelabo | Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0461958B1 (fr) * | 1990-06-15 | 1994-09-14 | Synthelabo | Dérivés de 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanes, leur préparation et leur application en thérapeutique |
FR2714055B1 (fr) * | 1993-12-22 | 1996-01-19 | Synthelabo | Dérivés de 5-(arylalkyl)-1,3-dioxane substitués en position 2, leur préparation et leur utilisation en thérapeutique. |
FR2742152B1 (fr) * | 1995-12-06 | 1998-01-16 | Synthelabo | Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique |
-
1998
- 1998-06-03 AU AU80251/98A patent/AU8025198A/en not_active Abandoned
- 1998-06-03 WO PCT/FR1998/001113 patent/WO1998055474A1/fr not_active Application Discontinuation
- 1998-06-03 KR KR1019997011436A patent/KR20010013435A/ko not_active Application Discontinuation
- 1998-06-03 IL IL13324298A patent/IL133242A0/xx unknown
- 1998-06-03 CA CA002290695A patent/CA2290695A1/fr not_active Abandoned
- 1998-06-03 CN CN98807817A patent/CN1265658A/zh active Pending
- 1998-06-03 HU HU0002166A patent/HUP0002166A3/hu unknown
- 1998-06-03 SK SK1661-99A patent/SK166199A3/sk unknown
- 1998-06-03 JP JP50172399A patent/JP2002502412A/ja active Pending
- 1998-06-03 EP EP98928419A patent/EP0986552A1/fr not_active Withdrawn
- 1998-06-03 PL PL98337234A patent/PL337234A1/xx unknown
- 1998-06-03 EE EEP199900560A patent/EE9900560A/xx unknown
- 1998-06-03 BR BR9810742-9A patent/BR9810742A/pt not_active IP Right Cessation
- 1998-06-03 TR TR1999/03022T patent/TR199903022T2/xx unknown
- 1998-06-03 AR ARP980102585A patent/AR012908A1/es unknown
- 1998-06-04 CO CO98031750A patent/CO4940480A1/es unknown
-
1999
- 1999-11-30 BG BG103937A patent/BG103937A/xx unknown
- 1999-12-03 NO NO995966A patent/NO995966L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0986552A1 (fr) | 2000-03-22 |
CA2290695A1 (fr) | 1998-12-10 |
CN1265658A (zh) | 2000-09-06 |
JP2002502412A (ja) | 2002-01-22 |
BR9810742A (pt) | 2000-09-12 |
HUP0002166A3 (en) | 2002-12-28 |
AR012908A1 (es) | 2000-11-22 |
CO4940480A1 (es) | 2000-07-24 |
NO995966D0 (no) | 1999-12-03 |
HUP0002166A2 (hu) | 2001-06-28 |
BG103937A (en) | 2000-07-31 |
AU8025198A (en) | 1998-12-21 |
TR199903022T2 (xx) | 2000-04-21 |
NO995966L (no) | 2000-02-04 |
PL337234A1 (en) | 2000-08-14 |
KR20010013435A (ko) | 2001-02-26 |
EE9900560A (et) | 2000-06-15 |
WO1998055474A1 (fr) | 1998-12-10 |
IL133242A0 (en) | 2001-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU703493B2 (en) | Therapeutic amides | |
EP0832069B1 (fr) | DERIVES DE BIPHENYL-2-ACIDE CARBOXYLIQUE-TETRAHYDRO-ISOQUINOLEINE-6-YL AMIDES, PREPARATION DE CES AMIDES ET UTILISATION EN TANT QU'INHIBITEURS DE LA PROTEINE DE TRANSFERT DE TRIGLYCERIDE MICROSOMAL ET/OU DE LA SECRETION D'APOLIPOPROTEINES B (Apo B) | |
DE69837346T2 (de) | Anilidderivate, deren herstellung und verwendung | |
FI114795B (fi) | Aroyylipiperidiinijohdannaiset | |
AU2005250197B2 (en) | Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics | |
KR20070103454A (ko) | 1,5-디아릴피롤 유도체, 그의 제조 방법, 및 치료제에서의그의 적용 | |
JP2007504120A (ja) | アダマンタン誘導体およびアザビシクロオクタン誘導体およびアザビシクロノナン誘導体、ならびにこれらの調製方法およびdpp−iv阻害剤としてのこれらの使用 | |
US5286735A (en) | Derivatives of 4-aminomethylpiperidine, their preparation and their use as therapeutics | |
JPWO2010107115A1 (ja) | グリシントランスポーター阻害物質 | |
CA2806821A1 (fr) | Compose de pyridine a cycle condense | |
US5789425A (en) | Imidazolidinone derivatives, their acid adducts and therapeutic drugs for senile dementia | |
SK166199A3 (en) | 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application | |
EP1567496B1 (fr) | Derives de phenyl-piperidin-4-ylidene-methyl-benzamide pour le traitement de la douleur et de troubles gastro-intestinaux | |
US5149709A (en) | Inhibitors of acyl-coenzyme A: cholesterol acyl transferase | |
US5922739A (en) | 5-Naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutical use thereof | |
CZ430699A3 (cs) | Deriváty 5-naftalen-l-yl-l,3-dioxanu, způsob jejich přípravy a jejich terapeutické využití | |
EP1181954A2 (fr) | Derives de biphenyl-2-acide carboxylique-tetrahydro-isoquinoleine-6-yl amides, preparation de ces amides et utilisation en tant qu'inhibiteurs de la proteine de transfert de triglyceride microsomal et/ou de la secretion d'apolipoproteines b (apo b) | |
ES2389754T3 (es) | Nuevos derivados de tiofendiamina con estructura urea | |
MXPA99011203A (en) | 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application | |
MXPA06009346A (en) | Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same | |
JPH10120644A (ja) | 2−ウレイド−ベンズアミド誘導体 |